Importance of predicting non-response to intravenous immunoglobulin therapy in non-Asian patients with Kawasaki disease

Importance of predicting non-response to intravenous immunoglobulin therapy in non-Asian patients with Kawasaki disease

Bibliographic Details
Main Authors:	Isabelle Koné-Paut, Maryam Piram
Format:	Article
Language:	English
Published:	Elsevier 2022-11-01
Series:	The Lancet Regional Health. Europe
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666776222002034

Similar Items

The characteristic laboratory findings of non-responsiveness to intravenous immunoglobulin in children with Kawasaki disease
by: Han Gil Cho, et al.
Published: (2010-02-01)

Pharmacogenomics of intravenous immunoglobulin response in Kawasaki disease
by: Sadeep Shrestha, et al.
Published: (2024-01-01)

Predictors of nonresponse to intravenous immunoglobulin therapy in Kawasaki disease
by: Hyo Min Park, et al.
Published: (2013-02-01)

Intravenous Immunoglobulin Resistant Kawasaki Disease
by: Mohammad Reza Navaeifar, et al.
Published: (2013-01-01)

Intravenous Immunoglobulin Resistant Kawasaki Disease
by: Mohammad Reza Navaeifar, et al.
Published: (2013-01-01)

Prediction of repeated intravenous immunoglobulin resistance in children with Kawasaki disease
by: Yaheng Lu, et al.
Published: (2021-09-01)

Still’s Disease in the Constellation of Hyperinflammatory Syndromes: A Link with Kawasaki Disease?
by: Perrine Dusser, et al.
Published: (2021-07-01)

Hemolytic anemia associated with intravenous immunoglobulin in Kawasaki disease
by: Eun Jung Cheon, et al.
Published: (2024-01-01)

Intravenous Immunoglobulin in Kawasaki Disease—Evolution and Pathogenic Mechanisms
by: Pallavi L. Nadig, et al.
Published: (2023-07-01)

Predictors and management of intravenous immunoglobulin-resistant Kawasaki disease
by: Min Seob Song
Published: (2019-04-01)

Predictive factors of resistance to intravenous immunoglobulin and coronary artery lesions in Kawasaki disease
by: Hye Young Lee, et al.
Published: (2016-12-01)

White Blood Cell and Neutrophil Counts and Response to Intravenous Immunoglobulin in Kawasaki Disease
by: Taichiro Muto MD, PhD, et al.
Published: (2019-10-01)

Effectiveness of two same-manufacturer intravenous immunoglobulin for Kawasaki disease
by: Kun-Lang Wu, et al.
Published: (2024-04-01)

Intravenous Immunoglobulin Treatment in Kawasaki Disease Decreases the Incidence of Myopia
by: Hun-Ju Yu, et al.
Published: (2021-03-01)

Use of Corticosteroid in Children with Unresponsiveness to Intravenous Immunoglobulin in Kawasaki Disease
by: Abdolkarim Hamedi, et al.
Published: (2017-08-01)

Hemolysis From Intravenous Immunoglobulin in Obese Patients With Kawasaki Disease
by: Khanh-Van Y. Van Anh, et al.
Published: (2020-04-01)

A comparison of efficacy of six prediction models for intravenous immunoglobulin resistance in Kawasaki disease
by: Weiguo Qian, et al.
Published: (2018-03-01)

Risk Factors and Predictive Models for Intravenous Immunoglobulin Resistance in Children with Recurrent Kawasaki Disease
by: Chen X, et al.
Published: (2022-05-01)

Comparison of risk scores for predicting intravenous immunoglobulin resistance in Taiwanese patients with Kawasaki disease
by: Chi-Nan Huang, et al.
Published: (2021-10-01)

Editorial: Pathogenesis, Clinical Findings, and Treatment Advances in Kawasaki Disease
by: Teresa Giani, et al.
Published: (2021-10-01)

NLRC4 methylation and its response to intravenous immunoglobulin therapy in Kawasaki disease: a case control study
by: Beirong Yu, et al.
Published: (2024-03-01)

Prediction of intravenous immunoglobulin retreatment in children with Kawasaki disease using models combining lymphocyte subset and cytokine profile in an East Asian cohort
by: Chun Zhang, et al.
Published: (2024-01-01)

Effect of Early Intravenous Immunoglobulin Therapy in Kawasaki Disease: A Systematic Review and Meta-Analysis
by: Fan Yan, et al.
Published: (2020-11-01)

Predictive value of albumin for intravenous immunoglobulin resistance in a large cohort of Kawasaki disease patients
by: Rui Zhang, et al.
Published: (2023-06-01)

Nomogram to predict risk of resistance to intravenous immunoglobulin in children hospitalized with Kawasaki disease in Eastern China
by: Hongbiao Huang, et al.
Published: (2022-12-01)

Comparison of Machine Learning Models for Prediction of Initial Intravenous Immunoglobulin Resistance in Children With Kawasaki Disease
by: Yasutaka Kuniyoshi, et al.
Published: (2020-12-01)

Prediction of unresponsiveness to second intravenous immunoglobulin treatment in patients with Kawasaki disease refractory to initial treatment
by: Euri Seo, et al.
Published: (2016-10-01)

Integrating Co-Clustering and Interpretable Machine Learning for the Prediction of Intravenous Immunoglobulin Resistance in Kawasaki Disease
by: Haolin Wang, et al.
Published: (2020-01-01)

Treatment response in Kawasaki disease is associated with sialylation levels of endogenous but not therapeutic intravenous immunoglobulin G.
by: Shohei Ogata, et al.
Published: (2013-01-01)

Clinical characteristics of aseptic meningitis induced by intravenous immunoglobulin in patients with Kawasaki disease
by: Matsuura Hiroyuki, et al.
Published: (2011-09-01)

Kawasaki Disease with Acute Respiratory Distress Syndrome after Intravenous Immunoglobulin Infusion
by: Yu Hyeon Choi, et al.
Published: (2014-11-01)

Peripheric arterial aneurisyms and monocytosis in intravenous immunoglobulin treatment resistant Kawasaki disease
by: Baskin E, et al.
Published: (2008-09-01)

A novel model for predicting intravenous immunoglobulin-resistance in Kawasaki disease: a large cohort study
by: Shuhui Wang, et al.
Published: (2023-07-01)

A decision tree model for predicting intravenous immunoglobulin resistance and coronary artery involvement in Kawasaki disease
by: Jinwoon Joung, et al.
Published: (2022-08-01)

Predictive Value of the Systemic Immune-Inflammation Index for Intravenous Immunoglobulin Resistance and Cardiovascular Complications in Kawasaki Disease
by: Xiaoliang Liu, et al.
Published: (2021-08-01)

Circulating Immune Cell Profile and Changes in Intravenous Immunoglobulin Responsiveness Over the Disease Course in Children With Kawasaki Disease
by: In Su Choi, et al.
Published: (2022-02-01)

Timing of Intravenous Immunoglobulin Treatment and Risk of Coronary Artery Abnormalities in Children with Kawasaki Disease
by: Aswine K. Bal, et al.
Published: (2014-10-01)

Comparative effectiveness of intravenous immunoglobulin for children with Kawasaki disease: a nationwide cohort study.
by: Ming-Chih Lin, et al.
Published: (2013-01-01)

Evaluation of Formosa score and diagnostic sensitivity and specificity of four Asian risk scores for predicting intravenous immunoglobulin resistance in Kawasaki disease: a bivariate meta-analysis
by: Wan-Ni Chiang, et al.
Published: (2023-06-01)

Novel Predictive Scoring System for Intravenous Immunoglobulin Resistance Helps Timely Intervention in Kawasaki Disease: The Chinese Experience
by: Yan Wang, et al.
Published: (2023-01-01)